JohnGallagherMD

PubMed

• Vitamin D and bone density, fractures, and falls: the end of the story?
  Gallagher, J. C.> ;Lancet Diabetes Endocrinol. 2018 Oct 09
• Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study.
  Bouchard C, Labrie F, Derogatis L, Girard G, Ayotte N, Gallagher J, Cusan L, Archer DF, Portman D, Lavoie L, Beauregard A, Côté I, Martel C, Vaillancourt M, Balser J, ...> ;Horm Mol Biol Clin Investig. 2016-03-01
• Bone mineral density measurements: how often should bone mineral density be measured in postmenopausal women? Results from the Women's Health Initiative study.
  Gallagher JC> ;Menopause. 2015-06-01
• Letter to the editor.
  Gallagher JC> ;Menopause. 2015-05-01
• Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study.
  Labrie F, Archer DF, Bouchard C, Girard G, Ayotte N, Gallagher JC, Cusan L, Baron M, Blouin F, Waldbaum AS, Koltun W, Portman DJ, Côté I, Lavoie L, Beauregard A, Labri...> ;Maturitas. 2015-05-01
• Biological agents in management of osteoporosis.
  Tella SH, Gallagher JC> ;Eur. J. Clin. Pharmacol.. 2014-11-01
• Efficacy of desvenlafaxine succinate for menopausal hot flashes.
  Tella, S. H.,Gallagher, J. C.> ;Expert Opin Pharmacother. 2014 Sep 26
• 46 citations
  Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women.
  J. C. Gallagher, Lynette M. Smith, Vinod Yalamanchili> ;Menopause. 2014 Nov 1
• Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD.
  Kaufmann M, Gallagher JC, Peacock M, Schlingmann K, Konrad M, DeLuca HF, Sigueiro R, Lopez B, Mourino A, Maestro M, St-Arnaud R, Finkelstein JS, Cooper DP, Jones G> ;J. Clin. Endocrinol. Metab.. 2014-07-01
• Prevention and treatment of postmenopausal osteoporosis.
  Tella SH, Gallagher JC> ;J. Steroid Biochem. Mol. Biol.. 2014-07-01
• Estrogen treatment does not reduce fractures?
  Gallagher JC> ;Menopause. 2014-02-01
• Controversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents?
  Gallagher JC, Tella SH> ;Clin Obstet Gynecol. 2013-12-01
• Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
  Tella, S. H.,Gallagher, J. C.> ;Expert Opin Pharmacother. 2013 Oct 08
• Changes in bone mineral density are correlated with bone markers and reductions in hot flush severity in postmenopausal women treated with bazedoxifene/conjugated estr...
  Gallagher JC, Shi H, Mirkin S, Chines AA> ;Menopause. 2013-11-01
• The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women.
  Gallagher JC, Yalamanchili V, Smith LM> ;J. Steroid Biochem. Mol. Biol.. 2013-07-01
• Effects of Vitamin D Supplementation in Older African American Women.
  Gallagher, J. C.,Peacock, M.,Yalamanchili, V.,Smith, L. M.> ;J Clin Endocrinol Metab. 2013 Mar
• Vitamin D deficiency and muscle strength: are they related?
  Gallagher JC> ;J. Clin. Endocrinol. Metab.. 2012-12-01
• The effect of vitamin D on calcium absorption in older women.
  Gallagher JC, Yalamanchili V, Smith LM> ;J. Clin. Endocrinol. Metab.. 2012-10-01
• Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype po...
  Yalamanchili V, Gallagher JC> ;Menopause. 2012-06-01
• IOM committee members respond to Endocrine Society vitamin D guideline.
  Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL> ;J. Clin. Endocrinol. Metab.. 2012-04-01
• Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization.
  Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN> ;Menopause. 2011-11-01
• Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.
  Sai AJ, Gallagher JC, Fang X> ;Menopause. 2011-10-01
• Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk.
  Boonen S, Adachi JD, Man Z, Cummings SR, Lippuner K, Törring O, Gallagher JC, Farrerons J, Wang A, Franchimont N, San Martin J, Grauer A, McClung M> ;J. Clin. Endocrinol. Metab.. 2011-06-01
• The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to know.
  Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA> ;J Am Diet Assoc. 2011-04-01
• Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass.
  Bone HG, Bolognese MA, Yuen CK, Kendler DL, Miller PD, Yang Y, Grazette L, San Martin J, Gallagher JC> ;J. Clin. Endocrinol. Metab.. 2011-04-01
• Join now to see all